Financhill
Sell
18

FOXO Quote, Financials, Valuation and Earnings

Last price:
$0.40
Seasonality move :
-25.88%
Day range:
$0.38 - $0.42
52-week range:
$0.38 - $13.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.11x
P/B ratio:
0.27x
Volume:
1.3M
Avg. volume:
7.8M
1-year change:
-88.24%
Market cap:
$2.6M
Revenue:
$4.1M
EPS (TTM):
-$7.20

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
FOXO
FOXO Technologies
-- -- -- -- --
DRIO
DarioHealth
$8.5M -$0.06 10.39% -29.16% $2.38
NRC
National Research
-- -- -- -- --
OTRK
Ontrak
$4.1M -- -13% -- $4.00
SPOK
Spok Holdings
$35.1M $0.24 3% 18.18% $20.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
FOXO
FOXO Technologies
$0.40 -- $2.6M -- $0.00 0% 0.11x
DRIO
DarioHealth
$0.72 $2.38 $31.4M -- $0.00 0% 1.06x
NRC
National Research
$13.51 -- $307.8M 13.12x $0.12 3.55% 2.25x
OTRK
Ontrak
$1.47 $4.00 $6.2M -- $0.00 0% 0.72x
SPOK
Spok Holdings
$16.20 $20.00 $333.3M 20.77x $0.31 7.72% 2.40x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
FOXO
FOXO Technologies
38.2% 17.122 144.44% 0.09x
DRIO
DarioHealth
28.37% -0.894 111.66% 1.76x
NRC
National Research
68.73% 0.821 23.29% 0.37x
OTRK
Ontrak
67.21% -0.416 155.76% 0.50x
SPOK
Spok Holdings
-- 0.393 -- 0.99x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
FOXO
FOXO Technologies
$1.3M -$1.5M -214.25% -- 8.49% -$1.3M
DRIO
DarioHealth
$3.9M -$9.4M -45.31% -63.94% -139.35% -$6.7M
NRC
National Research
$20.5M $8.6M 27.6% 70.08% 25.7% $3.7M
OTRK
Ontrak
$746K -$5.9M -144.37% -222.91% -290.04% -$2.8M
SPOK
Spok Holdings
$29.1M $6.1M 10.19% 10.19% 16.74% $1.5M

FOXO Technologies vs. Competitors

  • Which has Higher Returns FOXO or DRIO?

    DarioHealth has a net margin of -19.45% compared to FOXO Technologies's net margin of -136.66%. FOXO Technologies's return on equity of -- beat DarioHealth's return on equity of -63.94%.

    Company Gross Margin Earnings Per Share Invested Capital
    FOXO
    FOXO Technologies
    39.94% -$0.37 $15.7M
    DRIO
    DarioHealth
    57.49% -$0.14 $102.9M
  • What do Analysts Say About FOXO or DRIO?

    FOXO Technologies has a consensus price target of --, signalling downside risk potential of --. On the other hand DarioHealth has an analysts' consensus of $2.38 which suggests that it could grow by 232.12%. Given that DarioHealth has higher upside potential than FOXO Technologies, analysts believe DarioHealth is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    FOXO
    FOXO Technologies
    0 0 0
    DRIO
    DarioHealth
    3 1 0
  • Is FOXO or DRIO More Risky?

    FOXO Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.552, suggesting its more volatile than the S&P 500 by 55.239%.

  • Which is a Better Dividend Stock FOXO or DRIO?

    FOXO Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FOXO Technologies pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FOXO or DRIO?

    FOXO Technologies quarterly revenues are $3.2M, which are smaller than DarioHealth quarterly revenues of $6.8M. FOXO Technologies's net income of -$616.5K is higher than DarioHealth's net income of -$9.2M. Notably, FOXO Technologies's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FOXO Technologies is 0.11x versus 1.06x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FOXO
    FOXO Technologies
    0.11x -- $3.2M -$616.5K
    DRIO
    DarioHealth
    1.06x -- $6.8M -$9.2M
  • Which has Higher Returns FOXO or NRC?

    National Research has a net margin of -19.45% compared to FOXO Technologies's net margin of 17.25%. FOXO Technologies's return on equity of -- beat National Research's return on equity of 70.08%.

    Company Gross Margin Earnings Per Share Invested Capital
    FOXO
    FOXO Technologies
    39.94% -$0.37 $15.7M
    NRC
    National Research
    61.08% $0.25 $94.9M
  • What do Analysts Say About FOXO or NRC?

    FOXO Technologies has a consensus price target of --, signalling downside risk potential of --. On the other hand National Research has an analysts' consensus of -- which suggests that it could fall by --. Given that FOXO Technologies has higher upside potential than National Research, analysts believe FOXO Technologies is more attractive than National Research.

    Company Buy Ratings Hold Ratings Sell Ratings
    FOXO
    FOXO Technologies
    0 0 0
    NRC
    National Research
    0 0 0
  • Is FOXO or NRC More Risky?

    FOXO Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Research has a beta of 0.336, suggesting its less volatile than the S&P 500 by 66.395%.

  • Which is a Better Dividend Stock FOXO or NRC?

    FOXO Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research offers a yield of 3.55% to investors and pays a quarterly dividend of $0.12 per share. FOXO Technologies pays -- of its earnings as a dividend. National Research pays out 46.21% of its earnings as a dividend. National Research's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios FOXO or NRC?

    FOXO Technologies quarterly revenues are $3.2M, which are smaller than National Research quarterly revenues of $33.6M. FOXO Technologies's net income of -$616.5K is lower than National Research's net income of $5.8M. Notably, FOXO Technologies's price-to-earnings ratio is -- while National Research's PE ratio is 13.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FOXO Technologies is 0.11x versus 2.25x for National Research. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FOXO
    FOXO Technologies
    0.11x -- $3.2M -$616.5K
    NRC
    National Research
    2.25x 13.12x $33.6M $5.8M
  • Which has Higher Returns FOXO or OTRK?

    Ontrak has a net margin of -19.45% compared to FOXO Technologies's net margin of -341.65%. FOXO Technologies's return on equity of -- beat Ontrak's return on equity of -222.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    FOXO
    FOXO Technologies
    39.94% -$0.37 $15.7M
    OTRK
    Ontrak
    36.99% -$1.65 $14.2M
  • What do Analysts Say About FOXO or OTRK?

    FOXO Technologies has a consensus price target of --, signalling downside risk potential of --. On the other hand Ontrak has an analysts' consensus of $4.00 which suggests that it could grow by 172.11%. Given that Ontrak has higher upside potential than FOXO Technologies, analysts believe Ontrak is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    FOXO
    FOXO Technologies
    0 0 0
    OTRK
    Ontrak
    0 0 0
  • Is FOXO or OTRK More Risky?

    FOXO Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ontrak has a beta of 2.298, suggesting its more volatile than the S&P 500 by 129.787%.

  • Which is a Better Dividend Stock FOXO or OTRK?

    FOXO Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FOXO Technologies pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FOXO or OTRK?

    FOXO Technologies quarterly revenues are $3.2M, which are larger than Ontrak quarterly revenues of $2M. FOXO Technologies's net income of -$616.5K is higher than Ontrak's net income of -$6.9M. Notably, FOXO Technologies's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FOXO Technologies is 0.11x versus 0.72x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FOXO
    FOXO Technologies
    0.11x -- $3.2M -$616.5K
    OTRK
    Ontrak
    0.72x -- $2M -$6.9M
  • Which has Higher Returns FOXO or SPOK?

    Spok Holdings has a net margin of -19.45% compared to FOXO Technologies's net margin of 14.32%. FOXO Technologies's return on equity of -- beat Spok Holdings's return on equity of 10.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    FOXO
    FOXO Technologies
    39.94% -$0.37 $15.7M
    SPOK
    Spok Holdings
    80.13% $0.25 $151.7M
  • What do Analysts Say About FOXO or SPOK?

    FOXO Technologies has a consensus price target of --, signalling downside risk potential of --. On the other hand Spok Holdings has an analysts' consensus of $20.00 which suggests that it could grow by 23.46%. Given that Spok Holdings has higher upside potential than FOXO Technologies, analysts believe Spok Holdings is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    FOXO
    FOXO Technologies
    0 0 0
    SPOK
    Spok Holdings
    1 0 0
  • Is FOXO or SPOK More Risky?

    FOXO Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.515, suggesting its less volatile than the S&P 500 by 48.497%.

  • Which is a Better Dividend Stock FOXO or SPOK?

    FOXO Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.72% to investors and pays a quarterly dividend of $0.31 per share. FOXO Technologies pays -- of its earnings as a dividend. Spok Holdings pays out 176.29% of its earnings as a dividend.

  • Which has Better Financial Ratios FOXO or SPOK?

    FOXO Technologies quarterly revenues are $3.2M, which are smaller than Spok Holdings quarterly revenues of $36.3M. FOXO Technologies's net income of -$616.5K is lower than Spok Holdings's net income of $5.2M. Notably, FOXO Technologies's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 20.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FOXO Technologies is 0.11x versus 2.40x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FOXO
    FOXO Technologies
    0.11x -- $3.2M -$616.5K
    SPOK
    Spok Holdings
    2.40x 20.77x $36.3M $5.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock